Skip to main content

Posts

Showing posts with the label marburg virus disease

#Outbreak of #Marburg Virus Disease, Equatorial Guinea, 2023

Abstract In February 2023, the government of Equatorial Guinea declared an outbreak of Marburg virus disease . We describe the response structure and epidemiologic characteristics , including case-patient demographics, clinical manifestations, risk factors , and the serial interval and timing of symptom onset, treatment seeking, and recovery or death . We identified 16 laboratory-confirmed and 23 probable cases of Marburg virus disease in 5 districts and noted several unlinked chains of transmission and a case-fatality ratio of 90% (35/39 cases). Transmission was concentrated in family clusters and healthcare settings . The median serial interval was 18.5 days ; most transmission occurred during late-stage disease . Rapid isolation of symptomatic case-patients is critical in preventing transmission and improving patient outcomes; community engagement and surveillance strengthening should be prioritized in emerging outbreaks. Further analysis of this outbreak and a One Health surveillan...

Jamaican fruit #bats’ competence for #Ebola but not #Marburg virus is driven by intrinsic differences

Abstract Ebola virus (EBOV) and Marburg virus (MARV) are zoonotic filoviruses that cause hemorrhagic fever in humans . Correlative data implicate bats as natural EBOV hosts , but neither a full-length genome nor an EBOV isolate has been found in any bats sampled. Here, we model filovirus infection in the Jamaican fruit bat (JFB), Artibeus jamaicensis, by inoculation with either EBOV or MARV through a combination of oral, intranasal, and subcutaneous routes . Infection with EBOV results in systemic virus replication and oral shedding of infectious virus. MARV replication is transient and does not shed. In vitro, JFB cells replicate EBOV more efficiently than MARV, and MARV infection induces innate antiviral responses that EBOV efficiently suppresses. Experiments using VSV pseudoparticles or replicating VSV expressing the EBOV or MARV glycoprotein demonstrate an advantage for EBOV entry and replication early , respectively, in JFB cells. Overall, this study describes filovirus species-sp...

#Marburg virus disease– United Republic of #Tanzania

Situation at a glance On 13 March 2025, the Ministry of Health of the United Republic of Tanzania declared the end of the Marburg virus disease (MVD) outbreak.  This declaration came after two consecutive incubation periods (a total of 42 days) since the last person confirmed with MVD died on 28 January 2025 and was given a safe and dignified burial, in accordance with WHO recommendations.  No new confirmed cases were reported since then.  The outbreak was declared on 20 January 2025 . As of 12 March 2025, two confirmed and eight probable cases were reported by the Ministry of Health from Biharamulo district in Kagera region. All 10 cases died (case fatality ratio 100%), including eight who died before the confirmation of the outbreak. A total of 272 contacts that were listed for monitoring completed their 21-day follow-up as of 10 February 2025. WHO, through its country office, and partners provided technical, operational and financial support to the government to contai...

#Marburg Virus Disease–United Republic of #Tanzania

 {Excerpt} Situation at a glance Since the declaration of the Marburg Virus Disease (MVD) outbreak on 20 January 2025 in the United Republic of Tanzania, one additional confirmed death was reported by the Ministry of Health from the epicentre of the outbreak in Biharamulo district in Kagera region .  As of 10 February 2025, a cumulative of two confirmed and eight probable cases were reported by the Ministry of Health.  All 10 cases have died , including eight who died before the confirmation of the outbreak.  As of 10 February 2025, all 281 contacts that were listed and under monitoring have completed the 21-day follow-up.  The Ministry of Health developed a national response plan to guide activities. Additionally, a national rapid response team was deployed to the affected region to enhance outbreak investigation and response, with technical and operational support from WHO and health partners. Description of the situation Since the previous Disease Outbreak Ne...

#Tanzania confirms #outbreak of #Marburg virus disease

Dodoma, 20 January 2025 – Tanzania today confirmed an outbreak of Marburg virus disease in the northwestern Kagera region after one case tested positive for the virus following investigations and laboratory analysis of suspected cases of the disease . President of the Republic of Tanzania, Her Excellency Samia Suluhu Hassan , made the announcement during a press briefing alongside World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus , in the country’s administrative capital Dodoma. “Laboratory tests conducted in Kabaile Mobile Laboratory in Kagera and later confirmed in Dar es Salaam identified one patient as being infected with the Marburg virus. Fortunately, the remaining suspected patients tested negative ,” the president said. “We have demonstrated in the past our ability to contain a similar outbreak and are determined to do the same this time around.” A total of 25 suspected cases have been reported as of 20 January 2025 , all of whom have tested negati...

#Outbreak of suspected #Marburg Virus Disease - United Republic of #Tanzania

Description of the situation Introduction On 13 January 2025, WHO informed its Member States and IHR State Parties of an outbreak of suspected Marburg Virus Disease (MVD) in the Kagera region of the United Republic of Tanzania using our secure web-based platform—the Event Information Site (EIS). Under the International Health Regulations, the EIS is used to issue rapid alerts to Member States of acute and rapidly developing public health risks and events with possible international implications. Summary of the situation On 10 January 2025, WHO received reliable reports from in-country sources regarding suspected cases of MVD in the Kagera region of the United Republic of Tanzania. Six people were reported to have been affected , five of whom had died . The cases presented with similar symptoms of headache, high fever, back pain, diarrhoea, haematemesis (vomiting with blood), malaise (body weakness) and, at a later stage of disease, external haemorrhage (bleeding from orifices). As of 1...

#Marburg virus disease - #Rwanda

 {Summary} Situation at a glance On 20 December 2024, after two consecutive incubation periods (total of 42 days) since the second negative PCR test was conducted on 7 November for the last confirmed Marburg case, and without a new confirmed case reported , the Ministry of Health of Rwanda declared the end of the Marburg virus disease (MVD) outbreak , as per the WHO recommendations.  The outbreak had been declared on 27 September 2024 .  As of 19 December 2024, 66 confirmed cases,15 deaths with a case fatality ratio ( CFR) of 23%, and 51 recovered cases have been reported.  The last confirmed case was reported on 30 October 2024 .  WHO through its country office and development partners provided technical and financial support to the government to contain this outbreak.  The risk of re-emergence of MVD still remains even after the official declaration of the end of the outbreak, linked to viral persistence in body fluids (mostly semen) of recovered patients...